The COVID-19 ICU PRAYER Study

Sponsor
Kansas City Heart Rhythm Institute (Other)
Overall Status
Terminated
CT.gov ID
NCT04361838
Collaborator
(none)
200
1
2
11.3
17.7

Study Details

Study Description

Brief Summary

This is a multicenter; double blind randomized controlled study investigating the role of remote intercessory multi-denominational prayer on clinical outcomes in COVID-19 + patients in the intensive care unit. All patients enrolled will be randomized to use of prayer vs. no prayer in a 1:1 ratio. Each patient randomized to the prayer arm will receive a "universal" prayer offered by 5 religious denominations (Christianity, Hinduism, Islam, Judaism and Buddhism) in addition to standard of care. Whereas the patients randomized to the control arm will receive standard of care outlined by their medical teams. During ICU stay, patients will have serial assessment of multi-organ function and APACHE-II/SOFA scores serial evaluation performed on a daily basis until discharge. Data assessed include those listed below.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: prayer
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Supportive Care
Official Title:
Impact of Multi-Denominational Prayer on Morbidity and Mortality of Patients Admitted to the Intensive Care Unite With Corona Virus Infection
Actual Study Start Date :
May 21, 2020
Actual Primary Completion Date :
Apr 30, 2021
Actual Study Completion Date :
Apr 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Prayer

Patients will receive a daily prayer and standard of care treatment from multi-denominational group while in the ICU.

Behavioral: prayer
receive prayers daily while in ICU

No Intervention: No Prayer

Patients will receive standard of care treatment while in the ICU.

Outcome Measures

Primary Outcome Measures

  1. Impact of multi-denominational prayer on clinical outcomes of critically ill COVID-19 patients in the Intensive Care Unit on mortality. [daily until patient recovers and moves out of ICU or exits the study, up to 30 days]

    This study will measure the difference in mortality of COVID-19 patients who are admitted to ICU - given prayer vs no prayer as an adjunct to standard therapy.

Secondary Outcome Measures

  1. Difference in patient outcomes - Acute Physiology and Chronic Health Enquiry. APACHE II score. [daily until patient recovers and moves out of ICU or exits the study, up to 30 days.]

    APACHE II uses 0-71 scale, the higher the score the higher the risk for mortality.

  2. Difference in patient outcomes - Sequential Organ Failure Assessment - SOFA Score [daily until patient recovers and moves out of ICU or exits the study, up to 30 days]

    The higher the SOFA score the increased likelihood of organ failure.

  3. Difference in patient outcomes - Length of stay in ICU. [daily until patient recovers and moves out of ICU or exits the study, up to 30 days]

    A prolonged length of time in ICU increases mortality.

  4. Difference in patient outcomes - Length of ventilator support [daily until patient recovers and moves out of ICU or exits the study, up to 30 days]

    A prolonged length of time with ventilator support increases mortality.

  5. Difference in patient outcomes - length of vasopressor support [daily until patient recovers and moves out of ICU or exits the study, up to 30 days]

    A prolonged length of time with vasopressor support increases recovery time.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 110 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male or female greater than 18 years of age

  • Confirmed positive for COVID-19

  • Patient admitted to Intensive Care Unit

Exclusion Criteria:
  • Patients admitted to ICU for diagnosis that is not COVID-19 positive.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Research Medical Center Kansas City Missouri United States 64132

Sponsors and Collaborators

  • Kansas City Heart Rhythm Institute

Investigators

  • Principal Investigator: Dhanunjaya Lakkireddy, MD, Kansas City Heart Rhythm Institute

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Kansas City Heart Rhythm Institute
ClinicalTrials.gov Identifier:
NCT04361838
Other Study ID Numbers:
  • Covid Prayer Study
First Posted:
Apr 24, 2020
Last Update Posted:
Feb 3, 2022
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 3, 2022